𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic factors in myelodysplastic syndromes following myeloablative allogenic bone marrow transplantation-a twelve year follow up study

✍ Scribed by R. Lamba; E. Abella; R. Dansey; R. Baynes; J. Klein; C. Karanes


Book ID
116277709
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
69 KB
Volume
10
Category
Article
ISSN
1083-8791

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Myeloablative allogeneic bone marrow tra
✍ Erica D. Warlick; Paul V. O’Donnell; Michael Borowitz; Nichon Grupka; Lauren Dec πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier Science 🌐 English βš– 282 KB

Allogeneic blood and marrow transplantation (alloBMT) remains the only curative treatment for patients with myelodysplastic syndromes (MDS), but its application has been limited by the older age range of patients with this disease. T cell depletion decreases transplant-related toxicity related to gr

Analysis of factors related to the occur
✍ Sabah Sallah; Jim Y. Wan; Nam P. Nguyen; Paul Vos; George Sigounas πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 3 views

BACKGROUND. Chronic disseminated candidiasis (CDC) is a serious complication of treatment in patients with acute leukemia. Although some general risk factors are known to predispose to systemic fungal infections, few studies have addressed the relevance of certain clinical and laboratory features in